Re: Three Stages of Mold reference

[Guest guest]

I found the following text at:

http://www.aehf.com/articles/2003Symp.htm

SPEECH TITLE: " Pathology of Trichothecene Mycotoxins in Man "

Abstract Information & Notes

A. Croft, D.V.M., Ph.D.

Date of talk: Thursday, June 19, 2003, 2:00pm

Environmental Diagnostic Group Inc.

Phone: 715/757-3756

521 Hilltop

Dr.

Fax: 715/757-9302

Madison, WI

53711 E-

mail: doccroft@...

Veterinary School

Attended: University

of Minnesota

Medical School

Attended:

University of Wisconsin, Madison, Wisconsin

Major and date of

Graduation: Ph.D. in

Medical Pathology from the University of Wisconsin, Madison,

Wisconsin.

Current Job

Description:

Study Human diseases within the environment from outbreak of human

disease as a Medical Pathologist.

Other

Information:

Was on Faculty of the University of Wisconsin as Medical

Pathologist, was accepted by the National Institute of Health as a

Medical Pathologist, qualified to research human diseases. Obtain

over $900,000 of highly competitive research grants from the

national Institute of Health while at the University of Wisconsin.

Disclosure

Statement:

None

SPEECH TITLE: " Pathology of Trichothecene Mycotoxins in Man "

The speaker has provided the information below.

1.) Goals and objectives: To demonstrate the pathologic changes in

the primary target organs after inhalation verses ingestion exposure

to Trichothecene Mycotoxins in man.

2.) Outline of talk/abstract: A. History of Mycotoxicosis, B.

Detection of " Sick Buildings " ingestion verses inhalation exposure.

Signs and Symptoms expressed by over 6,000 patients exposed to

Trichothecene Mycotoxins, attempting to establish diagnosis. C.

The pathologic changes associated with inhalation exposure to

trichothecene mycotoxins. D. The primary organs involved with

inhalation Mycotoxicosis.

3.) Conclusion of what is to be learned: The primary target organs

of this disease and how this mycotoxin affects every cell in the

body.

4.) References:

a. Croft, W.A., Jarvis, B.B., and Yatawara, C.S.,: Airborne

Outbreak of Trichothecene Toxicosis, In: Atmospheric Environ, 20(3),

549-552 (1986).

b. Croft, W.A., Jastromski, B.M., Croft, A.L., and s,

H.A., " Clinical Confirmation of Trichothecene Mycotoxicosis In

Patient Urine, " In: Journal of Environmental Biology 23(3), 301-320

(2002).

The Pathology of Trichothecene Mycotoxicosis In Humans

1. The Fingerprint of the Agent Causing the Disease is

Displayed Within the Cells or Tissue of The Body.

2. Degeneration and Necrosis of The Entire Central Nervous

System, Cardiovascular, lung, Digestive Tract, Spleen, Liver,

Kidney, Pancreas, Immune, Skin, Reproductive, Eye, Urinary Bladder

and Prostate.

3. The Signs and Symptoms Described For Trichothecene

Mycotoxicosis Match the Pathology Observed.

4. Every Cell in The Body is Affected or Susceptible to

Trichothecene Mycotoxins When Exposed.

5. The Exposed Cells Are Not Allowed to Grow and Make Cellular

Products in The Rough Endoplasm Reticulum Represents of First

Mechanism of Action on The Cells.

6. The Burning or Denaturation of Tissue From the Epoxide

Molecule is Another Mechanism of Action on The Cells of The Body

Causing Intense Scarring of Organs. (Like Phenol)

7. The Rapidly Turnover Organs Systems Are Affected The Most

Severe, G.I. Tract, Immune System and Reproductive, (like radiation

damage)

8. The Central Nervous System is Severely Affected and is A

Primary Target Organ. The Neurons in the Cerebral Hemispheres,

White and Grey Matter, Brain Stem and even the Ependymal Cells. The

Purkinje Cells of The Cerebellum Are Severely Affected That Affect

Motion and Balance. The Dorsal and Ventral Motor Neurons Are

Destroyed Causing Amyotrophic Lateral Sclerosis. Peroxidation of

Peripheral Nerves is Also Observed. The Central Nervous System is

The Organ Most Affected as Reported By People Exposed to Toxic

Mold.

9. Lack of Cellular Production, Epoxide- Peroxidation of Lipid

Membranes, Loss of Vessels, Loss of Oxygen From Severe Lung

Scarring, and Loss of Proper Nutrients Due Loss of Functional

Absorption of Intestine Affect the Brain and All Organs of The Body.

10. The Trichothecene Mycotoxins are Cumulative in Their Health

Effects on Organ Systems.

11. Trichothecene Mycotoxins are " Hit and Run " Poisons and are

not Stored in The Body.

12. Inhalation of Trichothecene Mycotoxins Are More Poisonous As

Observed by The Intense Scarring of The Alveolar Tissue Than

Consumption Due To The Neutralization of Mycotoxin by Bacteria.

13. Depression of the Immune System Allows for Increase

Infections by Bacteria, Viral, Fungal and Cancer to Form.

14. Yeasts are allowed to Colonize the Intestine Tract Because

They Are Resistant to Trichothecene Mycotoxins.

15. Yeast Can Cause Diabetes Mellitus, Gout and Prevent Proper

Liver Function to Detoxify Xenobiotics.

16. Trichothecene Mycotoxins are Released Within the Urine and

Feces as Evidenced by The Pathology Observed Within Those Tissues.

17. Children Exposed to Trichothecene Mycotoxins are 100 to 1000

X more susceptible because stems are killed not allowing for

additional growth within the individual.

18. There is No Safe Level of Exposure to Trichothecene

Mycotoxins.

19. The third Mechanism For Trichothecene Mycotoxicosis is To

Develop Anaphylaxis to Mold Allergens When Mycotoxin Leaves The

Body.

Dr. Croft, (Medical Pathologist)

Stages of Mycotoxicosis: For Inhalation of Mycotoxin

The three Stages (1-3) ranging from lower to higher severity of

poisoning were modified according to exposure via the air as opposed

to ingestion already established (Forgacs et al., 1962; Joffe,

1971). A separate Stage of convalescence occurs when a patient is

completely removed from the contaminated premises and the source of

mycotoxin or mold spores.

Stage 1: The primary changes are in the brain, respiratory and

immune systems, mucus membranes and gastrointestinal tract. Signs

and symptoms may include burning sensation in the mouth, tongue,

throat, palate, esophagus, and stomach, which is a result of the

action of the toxin on the mucous membranes and skin in the exposed

areas. Moist areas of the body armpits, under breasts, belt line and

groin are more sensitive or first affected. Patients may report

burning within the eyes, ears and nose. Patients also reported that

their tongues felt swollen and stiff. Mucosa of the oral cavity may

be hyperemic. Mild gingivitis, stomatitis, glositis, and esophagitis

developed. Inflammation, in addition to gastric and (small and

large) intestinal mucosal, resulted in vomiting, diarrhea and

abdominal pain. Excessive salivation, headache, dizziness, weakness,

fatigue and tachycardia were also present.

There may be fever and sweating. The respiratory system develops

burning sensations and congestion. Severe exposure to mycotoxin

within the lungs may lead to congestion, edema and failure, due to

caustic action. Body temperature remains normal and controllable by

the patient. The poisoning appears and disappears relatively quickly

in this Stage with the exception of, lungs and central nervous

system. Initially (Stage 1), the patient's symptoms are very

uncomfortable or painful. As the poisoning continues and the patient

progress toward Stage 2, he or she becomes accustomed to the

presence of the mycotoxin and a quiescent period follows due to lack

of nerve sensation. Depending on exposure levels, the first Stage

may last from 3 - 9 days. In scoring the 50 signs and symptoms

listed in Tables-1 and 2, an average score range of 20-45 represents

Stage 1.

Stage 2 : This Stage is often called the latent Stage or incubation

period because the patient feels apprehensive, but is capable of

normal activity in the beginning of this Stage. Every organ of the

body is affected by degeneration and necrosis with continued

exposure. The primary target organs for an individual become evident

over time, due to biological variation. These are disturbances in

the central and autonomic nervous systems resulting in headaches,

mental depression, loss of short-term memory, loss of problem-

solving ability, various neuropsychiatric manifestations, meningism,

severe malaise and fatigue, narcolepsy, loss of temperature control,

hyperesthesia or numbness of body areas, and cerebellar dysfunction

including hypotonia, attitude and gait, dysmetria, asthenia,

vertigo, disturbances of speech, and loss of balance (Best, 1961).

Spinal cord degeneration may also be observed in gait and reflex

abnormalities, such as the ability to drive vehicles, ride bicycles

or pass sobriety tests (inability to tolerate ethyl alcohol).

Attention deficient disorder may be observed in children. Various

systems may include: Eyes: visual disturbances, floating objects,

light sensitive, lack of tears, burning and itching. Ears: burning,

itching, and loss of hearing. Immune and hematopoietic: progressive

loss of white and red cells including a decrease of platelets and

hemoglobin, and high susceptibility to bacterial, mycotic and viral

infections, debilitating chemical and allergies. Gastrointestinal:

metallic taste in mouth, tooth loss, gum problems, stomatitis, sores

in gums and throat, nausea, vomiting, diarrhea or constipation,

excessive flatulence, abdominal distention, hepatitis, pancreatitis,

and diabetes mellitus. Respiratory : burning and bleeding from nasal

membranes, respiratory difficulty, asthma, extreme susceptibility to

cold, flu and pneumonia. Skin: thinning of hair on head, burning on

face, rashes, irritation, and edema. Renal: proteinuria, possible

hematuria. Reproductive: irregular ovarian cycles, increased

menstrual flow, fibroid growths in uterus, cystic development in

mammary glands, and tumors of mammary and prostate glands.

Musculoskeletal : somatitis, muscle weakness, spasms, cramps, joint

pain, enlargement of joints in hand, and clubbing of fingers.

Cardiovascular: chest pain, palpitations, ruptures of atrial walls,

myocardial infection and aneurysm of arteries.

The skin and mucous membranes may be icteric, pupils dilated, the

pulse soft and labile, and blood pressure may decrease or increase.

The body temperature does not exceed 38 degree C and the patient may

be afebrile, or chilled. Visible hemorrhagic spots may appear on the

skin. Thoughts of suicide may be prominent in the person's mind at

this time or anytime in Stage 2. Human bonding is very important for

survival.

Degeneration and hemorrhages of the vessels marks the transition

from the second to the third Stage of the disease and may not be

consistently observed. The degeneration of the vital organs

including serious respiratory insufficiency or asthma and CNS

degeneration will take the patient into Stage three along with

development of necrotic angina. If exposure continues, depending on

exposure levels, Stage 2 may continue from weeks to months or even

years until the symptoms of the third Stage develop. Evaluating the

50 signs and symptoms (Table-1 and 2) by assigning a score (0-least

intense to 5-most intense or severe) to each symptom, we have

determined that an average score range of 45-180 represents Stage 2.

Stage 3: Severe degeneration of the vital organs. The transition

from the second to the third Stage is sudden. In this Stage, the

patient's resistance is already low, and violent severe symptoms are

present, especially under the influence of stress, or associated

with physical exertion and fatigue. The first visible sign of this

Stage may be lung, brain or heart failure (heart attack), with or

without the appearance of petechial hemorrhage on the skin of the

trunk, the axillary and inguinal areas, the lateral surfaces of the

arms and thighs, the face and head, and in serious Cases, the chest.

The petechial hemorrhages vary from a few millimeters to a few

centimeters in diameter. There is increased capillary fragility and

any slight trauma may cause the hemorrhages to increase in size.

Aneurysms of the brain or aorta may be observed by angiography.

Hemorrhages may also be found on the mucous membranes of the mouth

and tongue, and on the soft palate and tonsils. There may be severe

interstitial thickening or scarring of the lungs, or respiratory

failure. Nasal, gastric and intestinal hemorrhages and hemorrhagic

diathesis may occur. Necrotic angina begins in the form of catarrhal

symptoms and necrotic changes soon appear in the mouth, throat, and

esophagus with difficulty and pain on swallowing. Severe

degeneration of the skin on the face, eyelids, and loss of lashes is

also often present.

Necrotic lesions may extend to the uvula, gums, buccal mucosa,

larynx, vocal cords, lungs, stomach, and intestines and other

internal organs such as the liver and kidneys and are usually

contaminated with a variety of avirulent bacteria. Bacteria

infection causes an unpleasant odor from the mouth due to the

enzymatic activity of bacteria on proteins. Areas of necrosis may

also appear on the lips and on the skin of the fingers, nose, jaws,

and eyes. Regional lymph nodes are frequently enlarged. Esophageal

lesions may occur and involvement of the epiglottis may cause

laryngeal edema and aphonia (loss of voice). Death may occur by

strangulation.

Patients may suffer an acute parenchymatous hepatitis accompanied by

jaundice. Bronchopneumonia, pulmonary hemorrhages, and lung

abscesses are frequent complications. Tumors may develop of various

organs, including skin, urinary bladder, brain, mammary gland, bone,

immune, liver, prostate, possibly resulting in death. The most

common cause of death is brain failure due to both direct effects of

the mycotoxin on the central nervous system and indirect effects due

to respiratory failure or lack of oxygen to the brain caused by the

severe caustic inflammation (fibrinous exudation) reaction with the

lung tissue, rendering it non-functional. Again, using the scoring

system represented in Tables-1 and 2, an average score of greater or

equal 180 represents Stage 3.

Stage of Convalescence: The course and duration of this Stage 3

depends on the intensity of the poisoning and complete removal of

the patient from the premises or source of mycotoxin. Therefore, the

duration of the recovery period is variable. There is considerable

cellular necrosis and scarring to all major organs of the body in

which cells will not regenerate, including the brain, spinal cord,

eyes, lung, heart, liver, pancreas, kidney, adrenal, and blood

vessels. If the disease is diagnosed during the first Stage,

hospitalization is usually unnecessary, but allergies and asthma

should be monitored closely. If the disease is diagnosed during the

second Stage and even at the transition from the second to third

Stages, early hospitalization may preserve the patient's life. If

however, the disease is only detected during the third Stage, death

cannot be prevented in most Cases.

1. Croft, W. A., Jastromski, B. M., Croft, A. L., and s, H.

A., " Clinical

Confirmation of Trichothecene Mycotoxicosis in Patients

Urine " , In: Journal of

Environmental Biology 23(3), 301-320 (2002)

2. .Forgacs, J., and W. T. Carll : Mycotoxicoses. In : Advances in

Veterinary

Science. Academic Press, New York and London, pp 273-372

(1962).